Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Healthcare

Govt Releases Guidelines For Schemes To Boost Domestic Manufacturing Of Bulk Drugs, Med Devices

These schemes of the Department of Pharmaceuticals were approved by the Union Cabinet in March this year.

Read More

Telemedicine Can Help Bridge Us Gaps In The Healthcare Delivery System

Telemedicine can help us overcome the barriers to accessing healthcare services – distance between provider and patient, access to transportation, fragmented care caused due to gaps in appointments, and lack of healthcare access.

Read More

Cipla Gets India Approval To Sell COVID-19 Drug Favipiravir

The Drug Controller General of India granted Cipla accelerated approval to make and sell favipiravir in an effort to meet the "urgent and unmet" need for COVID-19 treatment options in the country

Read More

'Will Leave No Stone Unturned': India To Ensure Regulatory Facilitation For Trial Of Covid Vaccine

With the trials of COVID-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, the Serum Institute of India (SII) has said it will apply for license from the Indian regulator to start clinical trials of the shot in a week's time.

Read More

Glenmark Defends Price Of Its COVID-19 Drug Favipiravir Version

Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.

Read More

EU In Talks With Moderna, BioNtech, CureVac To Secure Possible COVID Vaccines

The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.

Read More

Infectious Disease Specialists Ask US Govt To Ensure Remdesivir Supply

"We urge the administration to fully leverage all authorities including the Defense Production Act and other tools to ensure adequate supplies of remdesivir," the IDSA said.

Read More

India Approves Human Trials For Second COVID-19 Vaccine Candidate

India's approval for Zydus comes days after privately held Bharat Biotech got a similar green light for human studies for its vaccine candidate.

Read More

Wall Street Shifts Bets To Big Pharma As COVID-19 Vaccine Race Progresses

Companies including Pfizer and Johnson & Johnson have said they each aim to produce as many as 1 billion doses by the end of 2021.

Read More

Covid-19 Vaccine Status: Here's All You Need To Know

Here is the latest update on COVID-19 vaccines from different pharmaceutical companies

Read More

BioNTech And Pfizer's COVID-19 Vaccine Shows Potential In Human Trial

The potential treatment is the fourth early-stage COVID-19 drug to show promise in human testing, along with projects involving Moderna, CanSino Biologics and Inovio Pharmaceuticals.

Read More

Oxford COVID-19 Vaccine Developers Encouraged By Immune Response But Cautious On Timeframe

"We're very happy that we're seeing the right sort of immune response that will give protection, and not the wrong sort," Gilbert said.

Read More

Gilead Prices COVID-19 Drug Remdesivir At $2,340 Per Patient In Developed Nations

Cipla's version is priced at less than 5,000 Indian rupees ($66.24), while Hetero Lab's version is priced at 5,400 rupees ($71.54).

Read More

Bharat Biotech Announces India's First COVID-19 Vaccine Candidate 'COVAXIN' With DCGI Approval For Human Clinical Trials

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Read More

Temasek-Led Investor Group In $250 Million Vaccine Bet On Biontech

The investors are in for an early reckoning because BioNTech has said it expects first clinical data on its COVID-19 vaccine development programme known as BNT162 this month or in July.

Read More